Pharma Bio Services (PBSV) has issued an update.
At Pharma-Bio Serv, Inc.’s 2024 Annual Meeting, stockholders approved an extension of the 2014 Long-Term Incentive Plan for an additional decade, now set to expire in 2034. The Board had previously endorsed this amendment, pending shareholder approval. In the director elections, Kirk Michel and Dov Perlysky were chosen as Class II directors, with their terms extending until the 2027 Annual Meeting. Additionally, Crowe PR PSC was ratified as the company’s independent accountants for the upcoming fiscal year, and the Plan Amendment was passed with a majority vote, despite a significant number of broker non-votes.
Learn more about PBSV stock on TipRanks’ Stock Analysis page.
